iRhythm Holdings, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.08M, a 42.44% decline year-over-year.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $149.00K, a 91.38% decline year-over-year.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $825.00K, a 457.43% increase year-over-year.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $7.09M, a 49.85% increase year-over-year.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $12.61M, a 48.79% increase from fiscal 2024.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $8.47M, a 3.93% decline from fiscal 2023.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $8.82M, a 33.10% decline from fiscal 2022.
- iRhythm Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $13.18M, a 47.41% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.08M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $149.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $12.61M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $825.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $7.09M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $1.73M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $8.47M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $148.00K 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $4.73M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | $604.00K 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $8.82M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $67.00K 10-Q · filed 2024-10-30 | $8.50M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $4.38M 10-Q · filed 2024-10-30 | $10.10M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $905.00K 10-Q · filed 2024-10-30 | $13.01M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $13.18M 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.66M 10-Q · filed 2023-11-02 | $13.32M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $7.30M 10-Q · filed 2023-11-02 | $11.74M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $1.08M 10-Q · filed 2023-11-02 | $8.44M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $8.94M 10-K · filed 2024-02-22 |
| 2021-09-30 | $80.00K 10-Q · filed 2022-11-04 | $12.22M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.00M 10-Q · filed 2022-08-05 | $16.46M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-06 | $18.85M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $20.24M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.32M 10-Q · filed 2021-11-05 | $16.77M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.39M 10-Q · filed 2021-08-09 | $13.45M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $2.97M 10-Q · filed 2021-05-10 | $10.34M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.49M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $3.29M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $9.32M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $6.39M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $132.00K 10-K · filed 2019-03-04 | |
| 2015-12-31 | $309.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $50.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |